Analyst consensus rating
Veradermics Analyst Rating: Strong Buy
Direct answer
Veradermics's consensus rating is Strong Buy.
6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $170.50.
Forecast evidence checked November 3, 2026.
Get free Veradermics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $129.53
- Average price target
- $170.50
- High price target
- $204.00
- Low price target
- $135.00
- Low target gap
- +4.2%
- Target upside
- +31.6%
- High target gap
- +57.5%
- Target range width
- 53.3%
- Consensus rating
- Strong Buy
- Analysts
- 6
- Evidence date
- November 3, 2026
- Valid through
- November 10, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Veradermics?
Veradermics has a verified Strong Buy consensus. The same dataset has an average price target of $170.50.
How far are Veradermics's low and high targets from the recorded price?
The low target implies +4.2%, while the high target implies +57.5%.
How many analysts are included in Veradermics's consensus?
The verified consensus includes 6 analysts.
How is Veradermics's target upside or downside calculated?
The average target of $170.50 is divided by the recorded price of $129.53, then one is subtracted to produce +31.6%. This does not guarantee a future return.
When was Veradermics's analyst forecast verified?
The data was verified on 2026-11-03. The dataset is valid through 2026-11-10.